Abstract
Nina N. Grenon, DNP, AGCNP-BC, AOCN®, of Dana-Farber Cancer Institute, evaluates data on RAS wild-type metastatic colorectal cancer, locally advanced mismatch repair–deficient rectal cancer, circulating tumor DNA tests, pancreatic neuroendocrine tumors, and nonresectable locally advanced pancreatic cancer. Kristen O’Hagan, MSN, ANP-BC, AOCNP®, of Memorial Sloan Kettering Cancer Center, reviews research on disparities in receiving guideline-concordant care among patients with colorectal cancer.
